Prefrontal TRPM8 Receptor Modulates Epileptic Seizures via PKA/CREB Signaling Pathway in Mice

Jia-Zhan Huang1,2, Gui-Feng Lu3, Yi-Han Jiang2

  • 1Department of Stomatology, Shantou University Medical College, Shantou, China.

PubMed
Abstract

Insights

Blocking prefrontal transient receptor potential melastatin 8 (TRPM8) receptors reduces seizure severity and neuronal apoptosis in a mouse model. This pathway involves the PKA/CREB signaling cascade, offering a potential therapeutic target for epilepsy treatment.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pharmacology

Background:

  • Epilepsy affects 50 million worldwide, often with cognitive impairments.
  • Transient receptor potential melastatin 8 (TRPM8) receptors are implicated in acute seizure models.
  • The precise role of prefrontal TRPM8 in seizure mechanisms remains largely unknown.

Purpose of the Study:

  • Investigate the upstream and downstream signaling pathways of prefrontal TRPM8 receptors.
  • Determine how TRPM8 jointly regulates seizure occurrence and progression.
  • Explore TRPM8 as a potential therapeutic target for seizure disorders.

Main Methods:

  • Established an acute mouse seizure model using pentylenetetrazol (PTZ).
  • Utilized stereotactic injections for region-specific TRPM8 channel blockade in the prefrontal cortex (PFC).
  • Analyzed seizure behavior, TRPM8 downstream signaling molecules (p-PKA, p-CREB), and neuronal apoptosis (TUNEL staining) post-PTZ induction.

Main Results:

  • TRPM8 receptors and downstream p-PKA/p-CREB levels were upregulated in the PFC during PTZ-induced seizures.
  • Inhibiting or knocking down TRPM8 in the PFC prolonged seizure latency and reduced seizure severity.
  • TRPM8 inhibition decreased prefrontal neuronal apoptosis, an effect counteracted by PKA activation.

Conclusions:

  • Prefrontal TRPM8 receptors are critical in PTZ-induced acute seizures.
  • The PKA/CREB pathway is a key downstream mediator of TRPM8's role in seizures.
  • Targeting prefrontal TRPM8 offers a promising therapeutic strategy for seizure management.